Clinical Chemistry · 2002 · 60 citations · 29 references
MedicineGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsPharmacogeneticsCytochrome P450 EnzymesGenotype-phenotype Association AnalysisGenotype-phenotype CorrelationMutation AnalysisPharmacogenetic TestingPharmacogenomic TestingCyp2d6 GenotypeCyp2d6 GenotypingCyp2d6 PharmacogeneticsCyp2d6 PhenotypingCytochrome P450 2D6Cytochrome P450 Genetic PolymorphismCytochrome P450 GenotypingReal-time Polymerase Chain Reaction (Pcr)
BACKGROUND: Single-nucleotide polymorphisms and single-base deletions within the cytochrome P450 2D6 (CYP2D6) gene have been associated with a poor metabolizer (PM) phenotype and display a frequency of 7-10% in the Caucasian population. METHODS: We developed a reliable and rapid procedure to identify five major PM-associated mutations (CYP2D6*4, *7, and *8) and deletions (CYP2D6*3 and *6) by real-time PCR with subsequent fluorometric melting point analysis of the PCR product. These polymorphisms within the CYP2D6 gene were detected by use of two primer pairs and five different pairs of hybridization probes. DNA extracted from whole blood of 323 individuals was analyzed, and results were compared with genotypes obtained by allele-specific multiplex PCR. In case of uncertain results, additional sequence analysis was performed. RESULTS: Genotyping results by real-time PCR were 100% reliable, whereas conventional allele-specific multiplex PCR produced uncertain results for 12.1% of samples, as confirmed by sequence analysis. Costs for reagents and consumables were considerably higher for the real-time PCR technology, but labor time was reduced by 2 h compared with allele-specific PCR. The allele frequencies in the population investigated were 0.186 for allele *4, 0.026 for allele *5, 0.009 for allele *3, 0.031 for allele *6, and 0.002 for allele *8. The defective CYP2D6*7 allele was not found. In addition, three additional mutations were detected, one of them displaying a PM genotype. CONCLUSION: Genotyping of CYP2D6 by real-time PCR with fluorometric melting point analysis is a rapid and reliable method.
29
Nomenclature for human CYP2D6 alleles
Ann K. Daly, Jürgen Brockmöller, Franck Broly et al. · Pharmacogenetics · 1996 · 400 citations
The hypoalgesic effect of tramadol in relation to CYP2D6*
Lars K. Poulsen, Lars Arendt‐Nielsen, Kim Brøsen et al. · Clinical Pharmacology & Therapeutics · 1996 · 387 citations